Haiying Sun

Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients

Yifan Meng, Ping Wu, Ping Wu et al. · PLoS Pathogens · 2020 · 381 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +9

Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors

Giuseppe Curigliano, Hans Gelderblom, Nicolas Mach et al. · Clinical Cancer Research · 2021 · 348 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment

Qian Cai, Haiying Sun, Yuefeng Peng et al. · Journal of Medicinal Chemistry · 2011 · 267 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAP

Haiying Sun, Zaneta Nikolovska‐Coleska, Jianfeng Lü et al. · Journal of the American Chemical Society · 2007 · 203 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP

Jianfeng Lü, Longchuan Bai, Haiying Sun et al. · Cancer Research · 2008 · 203 citations · Full text

Life Sciences, Oncology, Pharmacology +17